Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Core Laboratories Q1 2024 Adj EPS $0.19 Beats $0.16 Estimate, Sales $129.637M Beat $124.442M Estimate

Author: Benzinga Newsdesk | April 24, 2024 05:11pm

Core Laboratories (NYSE:CLB) reported quarterly Adj earnings of $0.19 per share which beat the analyst consensus estimate of $0.16 by 18.75 percent. The company reported quarterly sales of $129.637 million which beat the analyst consensus estimate of $124.442 million by 4.17 percent. This is a 1.00 percent increase over sales of $128.356 million the same period last year.

Posted In: CLB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist